ARCHIVES

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

In Brief: Allegra To Head NCI/Navy Branch; Sausville Promoted; Gladstein To Leave NCI For Dallas

October 25, 1991

O’Neill Account, Kennedy Hearing, Create Climate On Capitol Hill for Increasing Cancer Funding

May 3, 1991

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012